Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Parkinson's Disease

Free Subscription 27.04.2026 2 Ann Neurol 1 Exp Brain Res 2 J Neural Transm (Vienna) 1 J Neurochem 1 J Neurosci 1 Lancet 2 Mov Disord 1 Nat Med 1 Neuroscience 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. STANLEY CE JR, Fabrizio K, McMahon BA, Matthews-McGee A, et al
   Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI.
   Ann Neurol. 2026 Apr 21. doi: 10.1002/ana.78230.
   PubMed         Abstract available
   
   
2. MCGUIRE KUHL M, Destro C, Dobkin RD, Tropea TF, et al
   Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative.
   Ann Neurol. 2026 Apr 21. doi: 10.1002/ana.78220.
   PubMed         Abstract available
   
   

   
   Exp Brain Res

3. XIE B, Parker E, Deng Q, Yang L, et al
   Effects of exercise on alpha-synuclein in rodent models of Parkinson's disease: a systematic review and meta-analysis.
   Exp Brain Res. 2026;244:97.
   PubMed        
   
   

   
   J Neural Transm (Vienna)

4. KAMIYAMA D, Nishikawa N, Iwaki H, Ueno SI, et al
   Impact of catechol-O-methyltransferase inhibition on plasma homocysteine levels in levodopa-treated Parkinson's disease.
   J Neural Transm (Vienna). 2026 Apr 21. doi: 10.1007/s00702-026-03161.
   PubMed        
   
   
5. RUGOLO F, Nigro P, Romoli M, Sperandei S, et al
   Caregiver burden of parkinsonian patients with impulse control disorders, depression and apathy.
   J Neural Transm (Vienna). 2026 Apr 21. doi: 10.1007/s00702-026-03157.
   PubMed        
   
   

   
   J Neurochem

6. OBIKA S, Blesa J
   Antisense Oligonucleotides in Parkinson's Disease: Challenges, Opportunities, and the Promise of Low-Intensity Focused Ultrasound for Brain Delivery.
   J Neurochem. 2026;170:e70445.
   PubMed         Abstract available
   
   

   
   J Neurosci

7. BADELL-GRAU RA
   Rab27b: A Modulator of Lysosomal Function and Alpha-Synuclein Clearance in Parkinson's Disease.
   J Neurosci. 2026;46:e0917252026.
   PubMed        
   
   

   
   Lancet

8. ARCA VM, Parmera JB, Schuh AFS, Brandao PRP, et al
   Parkinson's disease: extending collaboration to Latin America.
   Lancet. 2026;407:1508.
   PubMed        
   
   

   
   Mov Disord

9. TOH TS, Lit LC, Lim SY, Hor JW, et al
   Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease.
   Mov Disord. 2026 Apr 20. doi: 10.1002/mds.70314.
   PubMed         Abstract available
   
   
10. FANG ZH, Grant RH, Vitale D, Hernandez CF, et al
    The Global Parkinson's Disease Genetics (GP2) Genome Browser.
    Mov Disord. 2026 Apr 19. doi: 10.1002/mds.70309.
    PubMed         Abstract available
    
    

    
    Nat Med

11. MENOZZI E, Ren Y, Geiger M, Macnaughtan J, et al
    Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals.
    Nat Med. 2026 Apr 20. doi: 10.1038/s41591-026-04318.
    PubMed         Abstract available
    
    

    
    Neuroscience

12. ASADPOORDEZAKI Z, Prehn JHM
    Neuronal vulnerability in Parkinson's disease: insights from murine alpha-synuclein pathology models.
    Neuroscience. 2026 Apr 17:S0306-4522(26)00261.
    PubMed         Abstract available
    
    

    
    PLoS One

13. MOLLAEI F, Evans H, Pool A
    Pause characteristics of sentence production in Parkinson's disease: Insights from sentence complexity and length.
    PLoS One. 2026;21:e0330808.
    PubMed         Abstract available
    
    
14. ZHAO L, Zhang B, Zhang Y, Jiang N, et al
    The phase average wavelength of alpha rhythm in EEG signals of patients with Parkinson's disease combined with cognitive impairment.
    PLoS One. 2026;21:e0344786.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

15. PONSI G, Villa R, Vico ID, Panasiti MS, et al
    Dopaminergic modulation of the sense of agency influences moral behavior in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2513356123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum